Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 29,700 shares at $113.18 ($3.4M) on 2020-09-02, disclosed to the SEC on 2020-09-03.
Open-market sale of $3.4M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.92 | 2,600 | $294K | 8.7% |
| 2 | $113.82 | 5,887 | $670K | 19.8% |
| 3 | $113.82 | 5,887 | $670K | 19.8% |
| 4 | $114.65 | 4,789 | $549K | 16.2% |
| 5 | $114.65 | 4,789 | $549K | 16.2% |
| 6 | $115.41 | 500 |
| $58K |
| 1.7% |
| 7 | $111.33 | 1,000 | $111K | 3.3% |
| 8 | $112.32 | 1,496 | $168K | 5.0% |
| 9 | $112.32 | 1,496 | $168K | 5.0% |
| 10 | $113.18 | 528 | $60K | 1.8% |
| 11 | $113.18 | 528 | $60K | 1.8% |
| 12 | $114.10 | 150 | $17K | 0.5% |
| 13 | $114.89 | 50 | $6K | 0.2% |
| Total | $113.78 avg | 29,700 | $3.4M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |